​

Invivyd (IVVD) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Invivyd Revenue Highlights

Latest Revenue (Y)

$25.38M

Latest Revenue (Q)

$13.13M

Main Segment (Y)

Product

Invivyd Revenue by Period

Invivyd Revenue by Year

DateRevenueChange
2024-12-31$25.38M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31--

Invivyd generated $25.38M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Invivyd Revenue by Quarter

DateRevenueChange
2025-09-30$13.13M11.39%
2025-06-30$11.79M4.26%
2025-03-31$11.30M-18.21%
2024-12-31$13.82M48.60%
2024-09-30$9.30M310.78%
2024-06-30$2.26M100.00%
2024-03-31--100.00%
2023-12-31$3.02M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30--

Invivyd generated $13.13M in revenue during Q3 2025, up 11.39% compared to the previous quarter, and up 579.90% compared to the same period a year ago.

Invivyd Revenue Breakdown

Invivyd Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Product$25.38M

Invivyd's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 25Jun 25Mar 25Dec 24Sep 24Jun 24
Product$13.13M$11.79M$11.30M$13.82M$9.30M$2.26M

Invivyd's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Product (100.00%).

Invivyd Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CDXSCodexis$59.34M$8.60M
SGMOSangamo Therapeutics$57.80M$581.00K
GNFTGenfit$28.57M$17.08M
OABIOmniAb$26.39M$2.24M
IVVDInvivyd$25.38M$13.13M
CCCCC4 Therapeutics$20.76M-
OBIOOrchestra BioMed$2.64M$861.00K
IMDXInsight Molecular Diagnostics$1.88M$260.00K
NTHINEONC TECHNOLOGIES$83.00K-
SLSSELLAS Life Sciences Group--
TARAProtara Therapeutics--

IVVD Revenue FAQ

What is Invivyd’s yearly revenue?

Invivyd's yearly revenue for 2024 was $25.38M, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. IVVD's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Invivyd’s quarterly revenue?

Invivyd's quarterly revenue for Q3 2025 was $13.13M, a 11.39% increase from the previous quarter (Q2 2025), and a 41.17% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $11.79M, a 4.26% increase from the previous quarter (Q1 2025), and a 420.58% increase year-over-year (Q2 2024). IVVD's quarterly revenue for Q1 2025 was $11.3M, a -18.21% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Invivyd’s revenue growth rate?

Invivyd's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.

What are Invivyd’s revenue streams?

Invivyd's revenue streams in c 24 are Product

What is Invivyd’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Invivyd was Product. This segment made a revenue of $25.38M, representing 100.00% of the company's total revenue.